Loading...
Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy
BACKGROUND: Paraneoplastic hyperleucocytosis (PH) is sporadically seen in patients with advanced solid tumors. CASE PRESENTATION: We report a female patient with disseminated melanoma metastases. Two days after the first dosage of combined immunotherapy using the cytotoxic T lymphocyte antigen-4 (CT...
Saved in:
| Published in: | J Immunother Cancer |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6208032/ https://ncbi.nlm.nih.gov/pubmed/30376886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0430-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|